213 related articles for article (PubMed ID: 29184405)
1. Absence of lung fibrosis after a single pulmonary delivery of lipid nanocapsules in rats.
Hureaux J; Lacoeuille F; Lagarce F; Rousselet MC; Contini A; Saulnier P; Benoit JP; Urban T
Int J Nanomedicine; 2017; 12():8159-8170. PubMed ID: 29184405
[TBL] [Abstract][Full Text] [Related]
2. α-bisabolol-loaded lipid-core nanocapsules reduce lipopolysaccharide-induced pulmonary inflammation in mice.
D'Almeida APL; Pacheco de Oliveira MT; de Souza ÉT; de Sá Coutinho D; Ciambarella BT; Gomes CR; Terroso T; Guterres SS; Pohlmann AR; Silva PM; Martins MA; Bernardi A
Int J Nanomedicine; 2017; 12():4479-4491. PubMed ID: 28684908
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers.
Zhao YQ; Wang LP; Ma C; Zhao K; Liu Y; Feng NP
Int J Nanomedicine; 2013; 8():4169-81. PubMed ID: 24204145
[TBL] [Abstract][Full Text] [Related]
4. Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel.
Hureaux J; Lagarce F; Gagnadoux F; Vecellio L; Clavreul A; Roger E; Kempf M; Racineux JL; Diot P; Benoit JP; Urban T
Eur J Pharm Biopharm; 2009 Oct; 73(2):239-46. PubMed ID: 19560538
[TBL] [Abstract][Full Text] [Related]
5. Lung inflammation does not affect the clearance kinetics of lipid nanocapsules following pulmonary administration.
Patel A; Woods A; Riffo-Vasquez Y; Babin-Morgan A; Jones MC; Jones S; Sunassee K; Clark S; T M de Rosales R; Page C; Spina D; Forbes B; Dailey LA
J Control Release; 2016 Aug; 235():24-33. PubMed ID: 27180635
[TBL] [Abstract][Full Text] [Related]
6. Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery.
Groo AC; Saulnier P; Gimel JC; Gravier J; Ailhas C; Benoit JP; Lagarce F
Int J Nanomedicine; 2013; 8():4291-302. PubMed ID: 24235827
[TBL] [Abstract][Full Text] [Related]
7. Toxicological study and efficacy of blank and paclitaxel-loaded lipid nanocapsules after i.v. administration in mice.
Hureaux J; Lagarce F; Gagnadoux F; Rousselet MC; Moal V; Urban T; Benoit JP
Pharm Res; 2010 Mar; 27(3):421-30. PubMed ID: 20054705
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells.
Valsalakumari R; Yadava SK; Szwed M; Pandya AD; Mælandsmo GM; Torgersen ML; Iversen TG; Skotland T; Sandvig K; Giri J
Int J Pharm; 2021 Mar; 597():120217. PubMed ID: 33486035
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel loaded PEG(5000)-DSPE micelles as pulmonary delivery platform: formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation.
Gill KK; Nazzal S; Kaddoumi A
Eur J Pharm Biopharm; 2011 Oct; 79(2):276-84. PubMed ID: 21575719
[TBL] [Abstract][Full Text] [Related]
10. Lipid nanocapsules as a new delivery system in copepods: Toxicity studies and optical imaging.
Stancheva S; Souissi A; Ibrahim A; Barras A; Spriet C; Souissi S; Boukherroub R
Colloids Surf B Biointerfaces; 2015 Nov; 135():441-447. PubMed ID: 26280818
[TBL] [Abstract][Full Text] [Related]
11. The adaptation of lipid nanocapsule formulations for blood administration in animals.
Hureaux J; Lagarce F; Gagnadoux F; Clavreul A; Benoit JP; Urban T
Int J Pharm; 2009 Sep; 379(2):266-9. PubMed ID: 19467305
[TBL] [Abstract][Full Text] [Related]
12. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
Roger E; Lagarce F; Garcion E; Benoit JP
J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
[TBL] [Abstract][Full Text] [Related]
13. Enhanced anti-tumor efficacy of paclitaxel with PEGylated lipidic nanocapsules in presence of curcumin and poloxamer: In vitro and in vivo studies.
Anwar M; Akhter S; Mallick N; Mohapatra S; Zafar S; Rizvi MMA; Ali A; Ahmad FJ
Pharmacol Res; 2016 Nov; 113(Pt A):146-165. PubMed ID: 27546165
[TBL] [Abstract][Full Text] [Related]
14. Lipid nanocapsules functionalized with polyethyleneimine for plasmid DNA and drug co-delivery and cell imaging.
Skandrani N; Barras A; Legrand D; Gharbi T; Boulahdour H; Boukherroub R
Nanoscale; 2014 Jul; 6(13):7379-90. PubMed ID: 24871584
[TBL] [Abstract][Full Text] [Related]
15. Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia.
Briot T; Roger E; Lautram N; Verger A; Clavreul A; Lagarce F
Int J Nanomedicine; 2017; 12():8427-8442. PubMed ID: 29200853
[TBL] [Abstract][Full Text] [Related]
16. Polymeric versus lipid nanocapsules for miconazole nitrate enhanced topical delivery:
Abdel-Rashid RS; Helal DA; Alaa-Eldin AA; Abdel-Monem R
Drug Deliv; 2022 Dec; 29(1):294-304. PubMed ID: 35037528
[TBL] [Abstract][Full Text] [Related]
17. A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy.
Zhang L; Tian B; Li Y; Lei T; Meng J; Yang L; Zhang Y; Chen F; Zhang H; Xu H; Zhang Y; Tang X
ACS Appl Mater Interfaces; 2015 Nov; 7(45):25147-61. PubMed ID: 26501354
[TBL] [Abstract][Full Text] [Related]
18. Lipid nanocapsules for transdermal delivery of ropivacaine: in vitro and in vivo evaluation.
Zhai Y; Yang X; Zhao L; Wang Z; Zhai G
Int J Pharm; 2014 Aug; 471(1-2):103-11. PubMed ID: 24858383
[TBL] [Abstract][Full Text] [Related]
19. Distribution of lipid nanocapsules in different cochlear cell populations after round window membrane permeation.
Zou J; Saulnier P; Perrier T; Zhang Y; Manninen T; Toppila E; Pyykkö I
J Biomed Mater Res B Appl Biomater; 2008 Oct; 87(1):10-8. PubMed ID: 18437698
[TBL] [Abstract][Full Text] [Related]
20. Treatment of 9L gliosarcoma in rats by ferrociphenol-loaded lipid nanocapsules based on a passive targeting strategy via the EPR effect.
Huynh NT; Morille M; Bejaud J; Legras P; Vessieres A; Jaouen G; Benoit JP; Passirani C
Pharm Res; 2011 Dec; 28(12):3189-98. PubMed ID: 21691892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
